Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRiC: BCG Revaccination vs Chemoprophylaxis in TB Contacts
NCT05330884Phase 3Suspended
- Sponsor
- National Institute for Research in Tuberculosis
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bcg vaccine in Tuberculosis (TB), sponsored by National Institute for Research in Tuberculosis. Started Jul 2024; status: suspended.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05330884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330884.